Latham & Watkins LLP has advised Mineralys Therapeutics. Cleary Gottlieb has represented the underwriters, including BofA Securities Inc., Goldman Sachs & Co. LLC, and Evercore Group...
Mineralys Therapeutics Announces Royalty Repurchase, $500 Million Debt Facility, and $150 Million Equity Offering
Mobia Medical Raises $150 Million in Initial Public Offering
Latham & Watkins LLP has advised Mobia Medical, Inc. Cleary Gottlieb has represented the underwriters. Mobia Medical, Inc., a commercial-stage medical device company, completed its initial...
Essex Property Trust’s $200 Million Add-On Senior Notes Offering
Latham & Watkins advised Essex Property Trust on the deal. Essex Property Trust, Inc.’s (NYSE: ESS) operating partnership, Essex Portfolio, L.P. closed an underwritten public offering...
Extra Space Storage’s $400 Million Notes Offering
Latham & Watkins advised Extra Space Storage on the offering. Extra Space Storage Inc. (NYSE: EXR), a leading owner and operator of self-storage facilities in the...
OneStream’s $490 Million IPO
Wilson Sonsini Goodrich & Rosati advised OneStream on the offering, Jones Day advised Kohlberg Kravis Roberts & Co. L.P. (“KKR”) and Latham & Watkins advised the...
Avidity Biosciences’ $461 Million Common Stock Offering
Latham & Watkins advised Avidity Biosciences, Inc. on the offering, and Wilson Sonsini Goodrich & Rosati advised Avidity on patent matters related to the transaction. Cooley...
Essex Property’s $350 Million Investment-Grade Bond Offering
Latham & Watkins represented Essex Property, while Alston & Bird represented an underwriting syndicate led by Wells Fargo, JP Morgan, PNC Capital Markets LLC, US Bancorp,...
Janux Therapeutics’ $296.5 Million Common Stock Offering
Cooley advised Janux Therapeutics on the offering and Wilson Sonsini Goodrich & Rosati advised Janux on patent matters. Latham & Watkins advised the underwriters. Janux Therapeutics,...
Structure Therapeutics’ US$300 Million Private Placement Equity Financing
Latham & Watkins LLP represents Jefferies LLC and Leerink Partners LLC acting as placement agents in the financing. Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global...
HilleVax’s €100 Million Common Stock Public Offering
Latham & Watkins Advises HilleVax on Pricing of Public Offering of Common Stock. HilleVax, Inc. (Nasdaq: HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing...
Janux Therapeutics’ $60 Million Offering of Common Stock and Pre-Funded Warrants
Cooley advised Janux, and Latham & Watkins advised the underwriter on the offering. Janux Therapeutics, Inc. (Nasdaq: JANX) has announced the pricing of an underwritten offering of...
Phathom Pharmaceuticals’ $130 Million Public Offering of Common Stock
Latham & Watkins advises Phathom Pharmaceuticals in pricing of US$130 million public offering of common stock. Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on developing and...